Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Market News
Market News
DARE
Market
Provider
Time
Symbols
News
Provider
2026.08.26
Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour Transcript
Seeking Alpha
2026.08.13
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Beats Revenue Estimates
Zacks
2026.08.12
Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates
Zacks
2026.08.11
Daré Bioscience, Inc. (DARE) Discusses Portfolio Advancements and Therapeutic Solutions for Women's Health Transcript
Seeking Alpha
2026.07.23
Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour Transcript
Seeking Alpha
2026.06.23
Daré Bioscience, Inc. (DARE) Presents at BIO International Convention 2026 - Slideshow (NASDAQ:DARE) 2026-06-23
Seeking Alpha
2026.05.15
Daré Bioscience, Inc. (DARE) Q1 2026 Earnings Call Transcript
Seeking Alpha
2026.05.12
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates
Zacks
2026.03.26
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates
Zacks
2026.03.26
Daré Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:DARE) 2026-03-26
Seeking Alpha
2026.03.16
Daré Bioscience extends NIH grant period for preterm birth drug
Investing
2026.03.09
Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates
Zacks
2026.03.02
uniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates
Zacks
2026.02.23
Daré Bioscience gets FDA clearance for HPV treatment trial
Investing
2026.01.29
Dare Bioscience launches preferred stock and warrant offering on Nasdaq
Investing
2025.12.02
Dare Bioscience stock maintains Buy rating at H.C. Wainwright as Bayer exits
Investing
2025.12.01
Daré Bioscience to regain rights to hormone-free contraceptive from Bayer
Investing
2025.11.24
Daré Bioscience receives $3.6 million grant payment for contraceptive work
Investing
2025.11.22
Daré Bioscience, Inc. (DARE) Discusses DARE to PLAY Sildenafil Cream as a Treatment Option for Female Genital Arousal Concerns Transcript
Seeking Alpha
2025.11.13
Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates
Zacks
2025.11.12
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Misses Revenue Estimates
Zacks
2025.11.10
Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates
Zacks
2025.11.06
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates
Zacks
2025.11.05
Arcellx, Inc. (ACLX) Reports Q3 Loss, Misses Revenue Estimates
Zacks
2025.11.04
AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates
Zacks
2025.10.06
Daré Bioscience receives $4 million grant installment for contraceptive device
Investing
2025.09.04
Maxim Group upgrades Dare Bioscience stock to Buy on funding boost
Investing
2025.08.18
Dare Bioscience stock price target lowered to $11 at Brookline Capital
Investing
2025.08.14
Daré Bioscience, Inc. (DARE) Q2 2025 Earnings Call Transcript
Seeking Alpha
2025.08.14
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
Zacks
1
>